Technical Developments in the Delivery of Antineoplastic Agents
Clinical cancer research has attracted much interest during recent years. Many new anticancer drugs and new treatment modalities are being developed. An important consequence is an increased need for reliable and safe methods of vascular access. Because most of the presently available anticancer drugs are administered intravenously, the greatest emphasis has been placed on venous access. However, intra-arterial and also intraperitoneal access are being investigated as a result of an increased interest in regional drug delivery.
- 1.van Groeningen CJ (1987) New technical developments in antineoplastic drug delivery and their role in cancer treatment. In: Domellöf L (ed) Drug delivery in cancer treatment, ESO monograph. Springer, Berlin Heidelberg New York, pp 39–52Google Scholar
- 2.Lokich JJ (ed) (1987) Cancer chemotherapy by infusion. MTP, LancasterGoogle Scholar